Zhen‐Bo Feng
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Gang ChenYi‐Wu DangRong‐Quan HeDianzhong LuoDandan XiongPeng LinDong‐yue WenLanshan Huang
- Topics
- Cancer-related molecular mechanisms research (31 papers)MicroRNA in disease regulation (23 papers)RNA modifications and cancer (17 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhen‐Bo Feng
93 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 1.2k
- Cancer Research 990
- Oncology 291
- Pulmonary and Respiratory Medicine 249
- Pathology and Forensic Medicine 136
Countries citing papers authored by Zhen‐Bo Feng
This map shows the geographic impact of Zhen‐Bo Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Bo Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Bo Feng more than expected).
Fields of papers citing papers by Zhen‐Bo Feng
This network shows the impact of papers produced by Zhen‐Bo Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Bo Feng. The network helps show where Zhen‐Bo Feng may publish in the future.
Co-authorship network of co-authors of Zhen‐Bo Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Zhen‐Bo Feng. A scholar is included among the top collaborators of Zhen‐Bo Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen‐Bo Feng. Zhen‐Bo Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 10 | |
| 6 | 3 | |
| 7 | 17 | |
| 8 | 14 | |
| 9 | 3 | |
| 10 | 22 | |
| 11 | 42 | |
| 12 | 12 | |
| 13 | 5 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | 18 | |
| 17 | 37 | |
| 18 | 53 | |
| 19 | 12 | |
| 20 | 5 |
About Zhen‐Bo Feng
Zhen‐Bo Feng is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 100 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (31 papers), MicroRNA in disease regulation (23 papers) and RNA modifications and cancer (17 papers). The work is most often cited by research in Cancer Research (990 citations), Molecular Biology (1.2k citations) and Oncology (291 citations). Zhen‐Bo Feng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Gang Chen, Yi‐Wu Dang, Rong‐Quan He, Dianzhong Luo, Dandan Xiong, Peng Lin, Dong‐yue Wen, Lanshan Huang, Kang‐Lai Wei and Fanghui Ren. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.